AMERISAFE (AMSF) has wrapped up FY 2025 with fourth quarter total revenue of US$81.6 million and basic EPS of US$0.55, alongside net income of US$10.4 million, putting a clear spotlight on how its workers’ compensation book is translating into bottom line results. The company has seen trailing twelve month revenue sit at US$317.3 million with EPS of US$2.48 and net income of US$47.1 million, giving investors a fuller view of how the latest quarter fits into the broader earnings trend. With net profit margins easing over the past year, this set of results leaves investors focused squarely on how sustainably AMERISAFE can protect its profitability.

See our full analysis for AMERISAFE.

With the headline numbers on the table, the next step is to see how this earnings picture lines up with the most common narratives around AMERISAFE’s growth, risk profile and long term profitability story.

Margins Under Pressure As Net Profit Eases

• Over the last 12 months, AMERISAFE’s net profit margin sat at 14.9%, compared with 17.9% in the prior year, alongside trailing net income of US$47.1 million on US$317.3 million of revenue.
• Consensus narrative leans on strong risk selection and high retention to support long term earnings stability, yet the shift from a 17.9% to 14.9% margin and quarterly net income moving from US$13.8 million in Q3 2025 to US$10.4 million in Q4 2025 shows that profitability is under pressure even as underwriting discipline remains a key part of the story.
  • Supporters of the consensus view point to combined ratios in the high 80s to low 90s in recent quarters, which is consistent with a business that is still underwriting profitably, even if margins are not as strong as a year earlier.
  • At the same time, trailing 12 month earnings declining by 11.6% per year over five years and the lower margin last year highlight that earnings stability is being tested, rather than simply confirmed, by the recent numbers.

Valuation Gap Versus DCF And Premium P/E

• AMERISAFE’s current share price of US$33.63 sits well below the DCF fair value of US$66.47, while the stock trades on a trailing P/E of 13.5x compared with a peer average of 8.4x and a US Insurance industry average of 12.5x.
• Bulls argue that the roughly 49% gap to the DCF fair value and a consensus analyst target of US$45.33 point to upside, yet the fact that the P/E is already higher than peers and the industry, alongside a trailing net margin that has moved from 17.9% to 14.9%, means the current valuation premium is being supported by weaker earnings than in prior years.
  • On the bullish side, trailing 12 month revenue of US$317.3 million and EPS of US$2.48 give a base of earnings that some investors compare to the DCF fair value of US$66.47 per share, which is materially above the market price.
  • Critics of the bullish stance point to the 11.6% annual decline in earnings over five years and the premium P/E multiple as signals that, even with a discounted share price versus DCF, the market is already paying more per dollar of current earnings than for many insurance peers.

If you want to see how optimistic investors are framing these numbers, the bullish case narrative goes into much more detail about the growth and margin story for AMERISAFE. 🐂 AMERISAFE Bull Case

Dividend Yield High, But Coverage Looks Thin

• The trailing dividend yield sits at 7.61%, and the payout is flagged as weakly covered by free cash flow over the last 12 months.
• Bears argue that multi year earnings decline of 11.6% per year and a 7.61% dividend that is not well covered by free cash flow could strain future payouts, and the recent step down in trailing net margin from 17.9% to 14.9% means there is less profit supporting that income stream.
  • From the cautious angle, trailing net income of US$47.1 million on US$317.3 million of revenue leaves less room to comfortably fund both dividends and any other capital returns if earnings stay at this level or lower.
  • What stands out for skeptics is that, even with these pressures, the shares still trade on a 13.5x P/E, above both the 8.4x peer average and 12.5x industry average, which they see as leaving limited room if dividend coverage does not improve.

Skeptical investors often focus on the income story, and the bearish narrative lays out why the high yield and softer margins keep them cautious on AMERISAFE. 🐻 AMERISAFE Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for AMERISAFE on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Seen both the bullish and cautious angles and still on the fence? Take a moment to weigh the trade off yourself and look at the 2 key rewards and 2 important warning signs to get a clearer picture of the balance between concerns and potential upsides.

See What Else Is Out There

AMERISAFE is facing thinner net margins, a multi year earnings decline of 11.6% per year and a dividend that recent free cash flow has not comfortably covered.

If you are concerned about pressured earnings and dividend coverage and want income that looks more robust, check out our 15 dividend fortresses today and compare options side by side.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.